Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Earnings
News

Milestone Pharmaceuticals Q4 EPS $(0.40) Down From $(0.23) YoY

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.40) per share. This is a 73.91 percent decrease over losses of $(0.23) per share from the same period last year.

byBenzinga Newsdesk

March 24, 2022

1 minute read

Milestone Pharmaceuticals (NASDAQ:MIST) reported quarterly losses of $(0.40) per share. This is a 73.91 percent decrease over losses of $(0.23) per share from the same period last year.